Autochthonous and persistent cutaneous larva migrans in an infant successfully treated by topic albendazole ointment

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e163-e164. doi: 10.1111/jdv.15356. Epub 2018 Dec 7.

Authors

M G Robert¹, A Faisant², O Cognet¹, M Rabodonirina³, F Peyron³, M Piquemal⁴, R Mazet⁴, H Pelloux¹, M P Brenier-Pinchart¹

Affiliations

¹ Parasitology-Mycology, University Hospital Grenoble-Alpes, Grenoble, France.
² Department of Pediatrics, University Hospital Grenoble-Alpes, Grenoble, France.
³ Parasitology-Mycology, Hospices Civils de Lyon, Lyon, France.
⁴ Pharmacotechny, Pharmacy, University Hospital Grenoble-Alpes, Grenoble, France.

PMID: 30468533
DOI: 10.1111/jdv.15356

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Cutaneous
Albendazole / administration & dosage*
Albendazole / therapeutic use
Anthelmintics / administration & dosage*
Anthelmintics / therapeutic use
Female
Hookworm Infections / drug therapy*
Hookworm Infections / transmission
Humans
Infant
Larva Migrans / drug therapy*
Larva Migrans / parasitology

Substances

Anthelmintics
Albendazole